Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Rockenstein

Showing results (11-20 of 197) with videos related to

Pageof 20
Sort By:
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|February 11, 2014
Role of neurotrophic factor alterations in the neurodegenerative process in HIV associated neurocognitive disordersJerel Fields, Wilmar Dumaop, T D Langford, et al.
Acta Neuropathologica|October 24, 2017
Multiple system atrophy: experimental models and realityCassia Overk, Edward Rockenstein, Elvira Valera, et al.
Acta Neuropathologica|November 30, 2006
Effects of Cerebrolysin on neurogenesis in an APP transgenic model of Alzheimer's diseaseEdward Rockenstein, Michael Mante, Anthony Adame, et al.
Experimental Neurology|March 18, 2004
Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTPDavid D Song, Clifford W Shults, Abbyann Sisk, et al.
Journal of Molecular Neuroscience : MN|September 6, 2002
Development of a new treatment for Alzheimer's disease and Parkinson's disease using anti-aggregatory beta-synuclein-derived peptidesManfred Windisch, Birgit Hutter-Paier, Edward Rockenstein, et al.
Journal of Molecular Neuroscience : MN|January 19, 2005
The Role of alpha-synuclein assembly and metabolism in the pathogenesis of Lewy body diseaseMakoto Hashimoto, Kohichi Kawahara, Pazit Bar-On, et al.
Journal of Neurochemistry|August 10, 2006
Effects of the cholesterol-lowering compound methyl-beta-cyclodextrin in models of alpha-synucleinopathyPazit Bar-On, Edward Rockenstein, Anthony Adame, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 6, 2002
Increased extracellular amyloid deposition and neurodegeneration in human amyloid precursor protein transgenic mice deficient in receptor-associated proteinEmily Van Uden, Margaret Mallory, Isaac Veinbergs, et al.
The Journal of Biological Chemistry|January 16, 2002
alpha-Synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cellsMakoto Hashimoto, Leigh J Hsu, Edward Rockenstein, et al.
Molecular Neurodegeneration|September 24, 2015
A brain-targeted, modified neurosin (kallikrein-6) reduces α-synuclein accumulation in a mouse model of multiple system atrophyBrian Spencer, Elvira Valera, Edward Rockenstein, et al.
Pageof 20

Showing results (11-20 of 197) with videos related to

Sort By:
Pageof 20
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|February 11, 2014
Role of neurotrophic factor alterations in the neurodegenerative process in HIV associated neurocognitive disordersJerel Fields, Wilmar Dumaop, T D Langford, et al.
Acta Neuropathologica|October 24, 2017
Multiple system atrophy: experimental models and realityCassia Overk, Edward Rockenstein, Elvira Valera, et al.
Acta Neuropathologica|November 30, 2006
Effects of Cerebrolysin on neurogenesis in an APP transgenic model of Alzheimer's diseaseEdward Rockenstein, Michael Mante, Anthony Adame, et al.
Experimental Neurology|March 18, 2004
Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTPDavid D Song, Clifford W Shults, Abbyann Sisk, et al.
Journal of Molecular Neuroscience : MN|September 6, 2002
Development of a new treatment for Alzheimer's disease and Parkinson's disease using anti-aggregatory beta-synuclein-derived peptidesManfred Windisch, Birgit Hutter-Paier, Edward Rockenstein, et al.
Journal of Molecular Neuroscience : MN|January 19, 2005
The Role of alpha-synuclein assembly and metabolism in the pathogenesis of Lewy body diseaseMakoto Hashimoto, Kohichi Kawahara, Pazit Bar-On, et al.
Journal of Neurochemistry|August 10, 2006
Effects of the cholesterol-lowering compound methyl-beta-cyclodextrin in models of alpha-synucleinopathyPazit Bar-On, Edward Rockenstein, Anthony Adame, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 6, 2002
Increased extracellular amyloid deposition and neurodegeneration in human amyloid precursor protein transgenic mice deficient in receptor-associated proteinEmily Van Uden, Margaret Mallory, Isaac Veinbergs, et al.
The Journal of Biological Chemistry|January 16, 2002
alpha-Synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cellsMakoto Hashimoto, Leigh J Hsu, Edward Rockenstein, et al.
Molecular Neurodegeneration|September 24, 2015
A brain-targeted, modified neurosin (kallikrein-6) reduces α-synuclein accumulation in a mouse model of multiple system atrophyBrian Spencer, Elvira Valera, Edward Rockenstein, et al.
Pageof 20